Medtech company Masimo announced it had received FDA De Novo clearance for Opioid Halo, the company's opioid overdose alert system.
The monitoring system aims to prevent overdose by alerting family members or caregivers when a patient is experiencing opioid-induced respiratory depression, or slowed or stopped breathing that can be fatal.
Opioid Halo includes four components: a fingertip sensor, a...
Irvine, California-based Masimo, makers of a suite of non-invasive patient monitoring devices and sensors, has expanded the capabilities of its connected platform to allow physicians to view more data, more clearly and in the configuration that works best for them.
Clinicians get a lot of data from Masimo’s bedside monitoring devices – which include the recently FDA-cleared forehead sensor,...
Irvine, California-based Masimo Technologies, which makes non-invasive patient monitoring devices and sensors, has received FDA 510(k) clearance for its forehead sensor.
The adhesive TFA-1 Forehead Sensor was developed to allow clinicians to monitor patients using pulse oximetry technology from an alternative site instead of a finger. Forehead sensors are easier to access during surgery and...
